BioPharmX Corp.
(NYSE Amex Equities : BPMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Producer Manufacturing » Miscellaneous Manufacturing
symbolcompany%chnglast%shortavg$volume
MTDMettler-Toledo International Inc.
0.08%681.315.4%$115.33m
AMEAMETEK, Inc.
0.84%89.102.1%$101.16m
DOVDover Corporation
0.14%96.051.3%$66.75m
CSLCarlisle Companies Incorporated
1.09%142.503.8%$44.67m
PNRPentair plc
1.75%37.822.9%$38.79m
CRCrane Co.
2.15%81.090.6%$21.22m
HIHillenbrand, Inc.
0.66%29.962.0%$18.00m
VMIValmont Industries, Inc.
0.86%135.741.3%$15.84m
WMSAdvanced Drainage Systems Inc
1.55%35.476.7%$15.04m
BRCBrady Corporation Class A
-0.23%53.900.9%$14.88m
SXIStandex International Corporation
0.68%71.451.4%$5.03m
TRSTriMas Corporation
1.09%29.571.1%$3.52m
RAVNRaven Industries, Inc.
1.36%32.701.3%$3.25m
LXFRLuxfer Holdings PLC Sponsored ADR
1.02%15.790.1%$2.92m
TGTredegar Corporation
-0.31%19.410.9%$2.22m

Company Profile

BioPharmX Corp. engages in the provision of healthcare products through platform technologies for pharmaceutical, over-the-counter, and supplement applications in dermatology. Its platforms include Topical Gel, Injectable, and Encapsulation. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Menlo Park, CA.